Pioneer Award Winners Katherine High, Amit Nathwani, Arthur Nienhuis, and Andrew Davidoff Honored

PRLog - Dec. 17, 2014 - NEW ROCHELLE, N.Y. -- Recognized for her pioneering work to develop gene therapy for hemophilia spanning several decades, taking it from the laboratory into human clinical trials, is Katherine A. High, MD , Spark Therapeutics. Also recognized for their demonstration of successful clinical applications of adeno-associated virus vector-based gene therapy for hemophilia B are Amit C. Nathwani, MD, PhD , UCL Cancer Institute, and Arthur W. Nienhuis, MD and Andrew M. Davidoff, MD , St. Jude Children's Research Hospital.



via New Rochelle Newswire http://ift.tt/1AHCBE5